Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...

BioNTech, a biotech company best known for its successful development of a messenger RNA Covid-19 vaccine, is acquiring fellow mRNA company CureVac in a $1.25 billion stock deal that brings ...

Covid-19 vaccine patent legal battle heading to Court of Appeal Moderna, Pfizer and BioNTech are locked in dispute over the rights to vaccine technology patents.

The new COVID-19 vaccine from Moderna, mNexspike, is made in a way that allows for a lower dose.

After federal health officials made abrupt changes to US Covid-19 vaccine recommendations for pregnant women last month, there’s new confusion and uncertainty about who can get the shots — and ...

On Aug. 26, Moderna sued fellow vaccine developers Pfizer and BioNTech, two companies that partnered to create a COVID-19 shot. Moderna accused Pfizer and BioNTech of patent infringement when ...

It may not be that easy to come by COVID vaccines this fall, due to new regulations Getting a COVID shot in the fall could potentially cost you $200 under the new changes What remains unclear ...

The European Patent Office has said it has invalidated a patent held by Moderna on mRNA-based COVID-19 vaccines, the latest development in an increasingly acrimonious dispute between the company ...

The Trump administration's COVID-19 vaccine policy changes mean anyone who is healthy and under 65 will likely have to pay out of pocket for the shot.